EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

High‐Flow Nasal Cannula in Hypercapnic Respiratory Failure: An Updated Systematic Review and Meta‐Analysis

Yongkang Huang iD, Na Li, Yajuan Qian, Mengyuan Shao, Shiyuan Gao, Zengli Zhang iD

The Clinical Respiratory Journal · 2026-07 · 20 (7)

DOI: 10.1111/crj.70207 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift The Clinical Respiratory Journal, online erschienen am 01.07.2026. Verfasst von Yongkang Huang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China. Hauptthemen laut MEDLINE: Respiratory Insufficiency, Hypercapnia, Cannula, Oxygen Inhalation Therapy. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Suzhou Science and Education Strengthening Health Project, Suzhou Applied Basic Research (Medical and Health) Science and Technology Innovation Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

High‐flow nasal cannula (HFNC) and bi‐level positive airway pressure (BiPAP) are both employed in the management of acute hypercapnic respiratory failure, yet their comparative benefits remain uncertain. We conducted an updated systematic review and meta‐analysis of randomized controlled trials (RCTs) to compare efficacy, safety, and tolerability of HFNC versus BiPAP in adults with hypercapnic respiratory failure.

Methods

We searched PubMed, Web of Science, the Cochrane Central Register of Controlled Trials (CENTRAL), CNKI, and Wanfang Data through June 2025 for RCTs enrolling patients aged ≥ 16 years with arterial carbon dioxide partial pressure (PaCO 2 ) > 45 mmHg. Primary outcomes were intubation rate and mortality. Secondary outcomes included arterial oxygen partial pressure (PaO2) or the ratio of PaO2 and inhaled oxygen fraction (FiO2; PaO 2 /FiO 2 ), PaCO 2 , pH, respiratory rate, intensive care unit (ICU) length of stay, patient comfort, and device‐related complications.

Results

Eleven RCTs ( n = 1069) met inclusion criteria. Intubation (risk difference [RD] = −0.02, 95% CI −0.06 to 0.03) and mortality rates (RD = −0.02, 95% CI −0.06 to 0.02) were similar between modalities. HFNC and BiPAP showed no significant difference in PaCO 2 reduction (mean differences [MD] = 0.74 mmHg; 95% CI, −1.21 to 2.70) or pH normalization (MD = −0.01; 95% CI, −0.01 to 0), or ICU stay (MD = −0.72 days; 95% CI, −1.90 to 0.46). However, BiPAP yielded minor statistically significant improvements in oxygenation (standardized mean differences [SMD] = 0.18, 0.03–0.33) and respiratory rate reduction (MD = 2.06; 95% CI, 1.17 to 2.94). HFNC achieved higher comfort scores and fewer skin or gastrointestinal complications.

Conclusion

HFNC and BiPAP offer comparable clinical outcomes in acute hypercapnic respiratory failure. BiPAP offers modest physiological advantages, whereas HFNC provides better patient comfort and less adverse events. Large‐scale, multicenter RCTs are needed to further delineate the comparative benefits of HFNC versus BiPAP in diverse patient groups.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Respiratory InsufficiencyHypercapniaCannulaOxygen Inhalation TherapyHumansRandomized Controlled Trials as TopicTreatment OutcomeOxygenIntensive Care Units

Stichwörter der Autor:innen

bi‐level positive airway pressurehigh‐flow nasal cannulahypercapniarespiratory failure

Substanzen

Oxygen

Autor:innen und Institutionen

  • Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.
  • Department of Medicine, Respiratory, Emergency and Intensive Care Medicine, The Fourth Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.

ORCID-Profile: Yongkang Huang, Zengli Zhang

Förderung

  • Suzhou Science and Education Strengthening Health Project
  • Suzhou Applied Basic Research (Medical and Health) Science and Technology Innovation Project

Zitieren

APA

Huang, Y., Li, N., Qian, Y., Shao, M., Gao, S., & Zhang, Z. (2026). High‐Flow Nasal Cannula in Hypercapnic Respiratory Failure: An Updated Systematic Review and Meta‐Analysis. The Clinical Respiratory Journal, 20(7). https://doi.org/10.1111/crj.70207

Vancouver

Huang Y, Li N, Qian Y, Shao M, Gao S, Zhang Z. High‐Flow Nasal Cannula in Hypercapnic Respiratory Failure: An Updated Systematic Review and Meta‐Analysis. The Clinical Respiratory Journal. 2026;20(7). doi:10.1111/crj.70207

BibTeX
@article{Huang2026,
  author = {Huang, Yongkang and Li, Na and Qian, Yajuan and Shao, Mengyuan and Gao, Shiyuan and Zhang, Zengli},
  title = {High‐Flow Nasal Cannula in Hypercapnic Respiratory Failure: An Updated Systematic Review and Meta‐Analysis},
  journal = {The Clinical Respiratory Journal},
  year = {2026},
  volume = {20},
  number = {7},
  doi = {10.1111/crj.70207}
}
Kostenlos starten →